Evofem Prices $50M Offering
socalTECH
MAY 18, 2021
San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women's contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term warrant.
Let's personalize your content